Evidence map›Paper›PMID 38825650›Full record

ArticleHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2024

May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey.

Rita Del Pinto, Claudia Agabiti Rosei, Claudio Borghi, Franco Cipollini, Santina Cottone, Giuseppe Antonio De Giorgi, Antonino Di Guardo, Maurizio Dugnani, Bruno Fabris, Cristina Giannattasio and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Challenges and Perspectives in Optimising the Treatment of Arterial Hypertension: Role of the Ramipril-Amlodipine-Hydrochlorothiazide Single-Pill Combination.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Review
  2. Hypertension Treatment with Angiotensin Receptor Blockers and Other Antihypertensive Agents: A Real-World Registry from a High-Volume Specialized Center Over TwoDecades.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Observational
  3. A Real-Life Survey on the Management of Arterial Hypertension in Italy.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Rita Del Pinto *Department of Life, Health and Environmental Sciences, Internal Medicine unit, ESH Excellence Center, S. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Claudia Agabiti Rosei *ESH Excellence Center, University of Brescia, Spedali Riuniti di Brescia, Italy.
Claudio BorghiESH Excellence Center, Sant'Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Franco CipolliniSan Jacopo Hospital, PIOT San Marcello Pistoiese, Pistoia, Italy.
Santina CottoneESH Excellence Center, P. Giaccone Hospital, University of Palermo, Palermo, Italy.
Giuseppe Antonio De GiorgiOutpatients Hypertension clinic, Lecce, Italy.
Antonino Di GuardoOutpatients Hypertension clinic, Catania, Italy.
Maurizio DugnaniOutpatients Hypertension clinic, Novara, Italy.
Bruno FabrisCattinara Hospital, University of Trieste, Trieste, Italy.
Cristina GiannattasioESH Excellence Center, Niguarda Hospital, University of Milano-Bicocca, Milan, Italy.
Gilberta GiacchettiAzienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Pietro MinuzESH Excellence Center, Policlinico G.B. Rossi, University of Verona, Verona, Italy.
Giuseppe MulèESH Excellence Center, P. Giaccone Hospital, University of Palermo, Palermo, Italy.
Pietro NazzaroHypertension clinic A.M.Pirrelli, University of Bari, Bari, Italy.
Gianfranco ParatiDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Marcello RattazziHypertension clinic, Cà Foncello Hospital, University of Padua, Treviso, Italy.
Francesca SaladiniHypertension clinic, Cittadella Hospital, Padua, Italy.
Massimo SalvettiDepartment of Medical and Surgical Sciences, Spedali Civili, University of Brescia, Brescia, Italy.
Riccardo SarzaniESH Excellence Center, IRCCS-INRCA, Università Politecnica delle Marche, Ancona, Italy.
Carmine SavoiaClinical and Molecular Medicine Department, Sapienza University, Rome, Italy.
Giuliano TocciClinical and Molecular Medicine Department, Sapienza University, Rome, Italy.
Franco VeglioDepartment Medical Sciences, ESH Excellence Center, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy.
Massimo VolpeIRCCS San Raffaele, Rome, Italy.
Vito VulpisEmergency Medicine, Hypertension and Cardiovascular Risk Unit-Policlinico Hospital, Bari, Italy.
Gianluca BaldiniDepartment of Life, Health and Environmental Sciences, Internal Medicine unit, ESH Excellence Center, S. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Claudio FerriDepartment of Life, Health and Environmental Sciences, Internal Medicine unit, ESH Excellence Center, S. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy. claudio.ferri@univaq.it.ORCID http://orcid.org/0000-0002-3594-2503
Maria Lorenza MuiesanESH Excellence Center, University of Brescia, Spedali Riuniti di Brescia, Italy.

Funding

CYTOKINES AND INFLAMMATORY BOWEL DISEASER01DK042191 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI COMINELLI, FABIO, PIZARRO, THERESA TORRES · 1995 to 2022
$4.7M
NIDDK NIH HHS R01 DK042191
6 · The paper itself

Abstract

introductionHypertension is the main risk factor for cardiovascular diseases (CVD). Notably, only about half of hypertensive patients manage to achieve the recommended blood pressure (BP) control. Main reasons for the persistence of uncontrolled BP during treatment are lack of compliance on the patients' side, and therapeutic inertia on physicians' side.

methodsDuring the global BP screening campaign "May Measure Month" (MMM) (May 1st to July 31st, 2022), a nationwide, cross-sectional, opportunistic study endorsed by the Italian Society of Hypertension was conducted on volunteer adults ≥ 18 years to raise awareness of the health issues surrounding high BP. A questionnaire on demographic/clinical features and questions on the use of fixed-dose single-pills for the treatment of hypertension was administered. BP was measured with standard procedures.

resultsA total of 1612 participants (mean age 60.0±15.41 years; 44.7% women) were enrolled. Their mean BP was 128.5±18.1/77.1±10.4 mmHg. About half of participants were sedentary, or overweight/obese, or hypertensive. 55.5% individuals with complete BP assessment had uncontrolled hypertension. Most were not on a fixed-dose combination of antihypertensive drugs and did not regularly measure BP at home. Self-reported adherence to BP medications was similar between individuals with controlled and uncontrolled BP (95% vs 95.5%).

conclusionsThis survey identified a remarkable degree of therapeutic inertia and poor patients' involvement in the therapeutic process and its monitoring in the examined population, underlining the importance of prevention campaigns to identify areas of unsatisfactory management of hypertension, to increase risk factors' awareness in the population with the final purpose of reducing cardiovascular risk.

Indexed as

Antihypertensive AgentsBlood PressureDrug CombinationsHealth Care SurveysHealth Knowledge, Attitudes, PracticeHypertensionMedication AdherenceAdultAgedAttitude of Health PersonnelCross-Sectional StudiesFemaleHumansItalyMaleMiddle AgedAntihypertensive AgentsDrug CombinationsBlood pressureHypertensionPrevention campaignsTherapeutic inertia

Identifiers

PMID38825650
PMCPMC11161440

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.